Concepedia

Volha Ninichuk

VN

Statistics

Publications

8

Citations

878

H-Index

8

Active since

2005

Affiliations

Ludwig-Maximilians-Universität München(Current)

University of Cologne

LMU Klinikum

Noxxon Pharma (Germany)

University Hospital Cologne

Volha Ninichuk is an author at Ludwig-Maximilians-Universität München specializing in inflammation, medicine, and cell signaling.

Publications per year

2005–2012

8

Publications

8

Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice

Volha Ninichuk, Stephan Segerer, Reinhard Hoffmann et al. · Kidney International · 2006 · 283 citations · Full text

, , +15

Spiegelmer Inhibition of CCL2/MCP-1 Ameliorates Lupus Nephritis in MRL-(Fas)lpr Mice

Onkar P. Kulkarni, Rahul D. Pawar, Werner G. Purschke et al. · Journal of the American Society of Nephrology · 2007 · 190 citations

, , +17

Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice

Volha Ninichuk, Onkar P. Kulkarni, Holger Schmid et al. · American Journal Of Pathology · 2008 · 135 citations · Full text

, , +11

Delayed Chemokine Receptor 1 Blockade Prolongs Survival in Collagen 4A3–Deficient Mice with Alport Disease

Volha Ninichuk, Christoph A. Reichel, Andrej Khandoga et al. · Journal of the American Society of Nephrology · 2005 · 103 citations

, , +17

The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice

Volha Ninichuk, Alexander G. Khandoga, Stephan Segerer et al. · American Journal Of Pathology · 2007 · 92 citations · Full text

, , +16

1–5 of 8